The protein C activity test checks how well protein C works in your blood. Protein C is a natural anticoagulant, which means it helps keep clotting under control after a clotting response has started. When protein C activity is low, the body has less ability to turn down clot formation, especially in the veins. This raises concern for a thrombophilia, a tendency toward blood clots.
A low result does not automatically mean you have an inherited protein C deficiency. Warfarin, vitamin K deficiency, liver disease, severe infection, disseminated intravascular coagulation, recent thrombosis, and improper timing of the test all affect results. That is why clinicians usually repeat the test and compare it with protein C antigen and other clotting studies before making a diagnosis.
This test matters most when someone has unexplained, recurrent, early-age, or unusual-location blood clots, or a strong family history of venous thromboembolism.
- Protein C activity measures function, not just amount: it shows whether protein C is working well enough to help slow clot formation.
- A common adult reference range is about 70% to 150%, but each laboratory sets its own range.
- Protein C activity below about 60% to 70% raises concern for deficiency after acquired causes and medication effects are excluded.
- Low protein C is linked mainly to venous clots, especially deep vein thrombosis and pulmonary embolism.
- Warfarin lowers protein C activity, so testing during warfarin therapy often gives misleading low results.
- High protein C activity usually has no clear clinical meaning and is not considered a standard marker of excess clotting or bleeding risk.
Table of Contents
- What Protein C Activity Measures
- When the Protein C Activity Test Is Ordered
- Normal Range and What Results Mean
- Causes of Low Protein C Activity
- Inherited Protein C Deficiency and Blood Clot Risk
- Timing, Preparation, and Test Accuracy
- Follow-Up Tests After an Abnormal Result
- Treatment and Next Steps
What Protein C Activity Measures
The protein C activity test measures how well protein C performs its anticoagulant job. It is a functional test. Instead of asking only “how much protein C is present,” it asks “does the protein C in this blood sample work properly?”
Protein C is made in the liver and depends on vitamin K. After it circulates in the blood, it becomes activated on the lining of blood vessels through a thrombin-thrombomodulin system. Activated protein C then helps shut down clotting by inactivating factors Va and VIIIa. These clotting factors normally help generate thrombin, a key enzyme that builds fibrin clots. By turning down factors Va and VIIIa, activated protein C helps prevent a clot from growing larger than needed.
Protein C does not work alone. Protein S acts as an important helper protein. A low or abnormal protein S activity test result creates a similar concern because protein S supports activated protein C. Antithrombin is another natural anticoagulant, and an abnormal antithrombin activity test also belongs in the broader evaluation of inherited or acquired clotting tendency.
The body needs a careful balance. Too little clotting causes bleeding. Too much clotting causes thrombosis. Protein C is one of the systems that keeps clotting from spreading through the bloodstream after the body has already sealed an injury.
A protein C activity test is different from a protein C antigen test:
| Test | What it measures | Why it matters |
|---|---|---|
| Protein C activity | How well protein C works | Best first test for detecting both low quantity and poor function |
| Protein C antigen | How much protein C is present | Helps classify the type of deficiency after activity is low |
A person with type I protein C deficiency has low activity and low antigen because the body does not make enough protein C. A person with type II protein C deficiency has low activity with normal or near-normal antigen because the protein is present but does not work correctly.
This distinction matters because two people with the same “low protein C” label do not always have the same biological problem.
When the Protein C Activity Test Is Ordered
The protein C activity test is usually ordered when the pattern of blood clots suggests an underlying clotting tendency. It is not a routine screening test for healthy adults, and it is not needed after every blood clot.
Clinicians most often consider protein C activity testing after:
- A deep vein thrombosis, especially before age 50
- A pulmonary embolism without a clear temporary trigger
- Recurrent venous blood clots
- A clot in an unusual site, such as the cerebral, portal, mesenteric, renal, or hepatic veins
- A strong family history of venous thromboembolism
- Warfarin-related skin necrosis
- Severe clotting problems in a newborn, especially purpura fulminans
- A known protein C deficiency in a close relative
The test also appears in thrombophilia workups. A thrombophilia workup looks for inherited or acquired conditions that increase blood clot risk. These often include protein C deficiency, protein S deficiency, antithrombin deficiency, factor V Leiden, prothrombin gene mutation, and antiphospholipid syndrome. If factor V Leiden is suspected, an activated protein C resistance test is often used as part of the evaluation. If antiphospholipid syndrome is a concern, clinicians often order an antiphospholipid antibody panel.
Protein C activity testing is most useful when the result will change a medical decision. Examples include deciding whether to test relatives, planning pregnancy care in someone with a strong family history, evaluating a young person with recurrent clots, or choosing safe anticoagulation around surgery or long-term therapy.
Testing is less useful when a clot has a clear major trigger, such as major surgery, major trauma, prolonged hospitalization, or a central venous catheter, and no personal or family pattern suggests inherited thrombophilia. In those cases, the temporary trigger often explains the clot better than an inherited deficiency.
The test also does not diagnose an active clot. Imaging diagnoses most clots. A D-dimer blood test sometimes helps rule out a clot in low-risk situations, but protein C activity testing answers a different question: whether a person has reduced natural anticoagulant activity that raises future clot risk.
Normal Range and What Results Mean
A typical adult protein C activity reference range is about 70% to 150%. Some laboratories use ranges such as 65% to 135% or 70% to 130%. The correct range is the one printed on your laboratory report, because methods and calibration differ.
Protein C activity is often reported as a percentage. A result of 100% means the sample has activity close to the laboratory’s normal reference standard. It does not mean “perfect health,” and it does not mean zero clot risk.
| Result pattern | Common meaning | Important caution |
|---|---|---|
| Within the reference range | Protein C function appears normal in that sample | Normal protein C does not rule out all clotting disorders |
| Mildly low | Possible acquired reduction, medication effect, lab interference, or mild inherited deficiency | Repeat testing is often needed |
| Below about 60% to 70% | Raises stronger concern for protein C deficiency | Inherited deficiency should not be diagnosed until acquired causes are excluded |
| Very low, especially near absent | Possible severe congenital deficiency in the right clinical setting | In newborns, age-specific ranges are essential |
| High | Usually no established clinical significance | High protein C is not a standard cause of bleeding |
Low protein C activity is the main clinically important abnormal result. It means protein C is not slowing clot formation as expected in the test system. That finding raises concern for excess clotting tendency, especially when the person has a history of venous clots.
A low result does not tell the whole story. It does not prove that a current symptom is a clot. It does not predict the exact date or location of a future clot. It also does not automatically mean lifelong anticoagulation is needed. The result must be interpreted with the person’s clot history, family history, medications, age, pregnancy status, liver function, vitamin K status, and other clotting tests.
A high protein C activity result rarely drives medical decisions. Unlike low protein C, high protein C does not have a well-established link to a specific disease pattern. Laboratories usually focus interpretation on whether activity is low enough to suggest deficiency.
For children, especially infants, adult reference ranges are not appropriate. Newborns normally have lower protein C levels than adults. Protein C rises over the first months of life, so pediatric interpretation needs age-specific reference intervals.
Causes of Low Protein C Activity
Low protein C activity has two broad categories: acquired and inherited. Acquired causes are more common in everyday testing and must be considered before labeling someone with inherited protein C deficiency.
Medication effects
Warfarin is one of the most important causes of low protein C activity. Warfarin blocks vitamin K recycling, which lowers vitamin K-dependent clotting factors and natural anticoagulants, including protein C. Because protein C has a relatively short half-life, it falls early after warfarin starts. This is one reason warfarin initiation requires careful management, especially in people suspected of having protein C deficiency.
Do not stop warfarin or any anticoagulant to “clean up” a test result without medical direction. Stopping anticoagulation at the wrong time raises clot risk. Clinicians often delay testing, use alternative timing, or bridge therapy when accurate inherited thrombophilia testing is important.
Direct oral anticoagulants and heparin also interfere with some clot-based assays. The degree of interference varies by method. Chromogenic protein C assays are generally less vulnerable to some clot-based interferences, but the laboratory method still matters.
Vitamin K deficiency and liver disease
Protein C is vitamin K-dependent and made in the liver. Vitamin K deficiency and impaired liver synthesis both lower protein C activity. Vitamin K deficiency results from poor intake, fat malabsorption, bile flow problems, prolonged antibiotic use in selected settings, or other medical conditions. When vitamin K status is relevant, a vitamin K blood test or related vitamin K-dependent markers sometimes help clarify the picture.
Liver disease also lowers protein C because the liver produces protein C. In that setting, low protein C reflects reduced liver synthetic function rather than inherited thrombophilia. A hepatic function panel, albumin, bilirubin, and prothrombin time often provide important context.
Consumption during severe illness or clotting activation
Protein C activity drops when the body consumes clotting and anticoagulant proteins during severe systemic illness. Disseminated intravascular coagulation, severe infection, sepsis, trauma, and widespread inflammation all distort protein C results.
Testing during or soon after an acute thrombosis also gives unreliable answers. A fresh clot and the body’s response to it change several coagulation proteins. Testing too early often creates a low result that later normalizes.
Age and pregnancy-related interpretation
Newborns normally have lower protein C activity than adults. A low adult-style number in a newborn does not automatically mean disease. Severe inherited deficiency in a newborn is a medical emergency, but interpretation requires pediatric ranges and the clinical picture.
Pregnancy changes the clotting system and raises clot risk through several mechanisms. Protein C itself is usually less affected than protein S, but pregnancy is still a difficult time to interpret thrombophilia tests. Clinicians often avoid making a final inherited thrombophilia diagnosis from testing done during pregnancy or immediately after delivery unless there is an urgent reason.
Inherited protein C deficiency
Inherited protein C deficiency comes from changes in the PROC gene. It is uncommon, but it is one of the classic inherited thrombophilias. Some people inherit one altered copy and have mild to moderate deficiency. Rarely, a child inherits severe deficiency from both sides and presents in the newborn period with life-threatening clotting and skin findings.
Inherited deficiency is more likely when protein C activity stays low on repeat testing, acquired causes are absent, and the person has a personal or family history of venous thrombosis.
Inherited Protein C Deficiency and Blood Clot Risk
Inherited protein C deficiency increases the tendency for venous blood clots. The most common clot types are deep vein thrombosis and pulmonary embolism. Less common sites include veins in the brain, abdomen, liver, kidney, or eye, depending on the person’s full risk profile.
The result is not destiny. Some people with inherited protein C deficiency never have a clot. Others develop recurrent clots, especially when another risk factor is present. Risk rises during high-risk periods such as major surgery, hospitalization, prolonged immobility, pregnancy and the postpartum period, estrogen-containing contraception, hormone therapy, major injury, active cancer, or long-distance travel with limited movement.
Inherited protein C deficiency is usually discussed in two laboratory types:
| Type | Protein C activity | Protein C antigen | Meaning |
|---|---|---|---|
| Type I | Low | Low | The body makes too little protein C |
| Type II | Low | Normal or near normal | The body makes protein C that does not work properly |
This classification helps confirm the diagnosis, but clot history still matters more than the label alone. A person with a previous unprovoked pulmonary embolism and persistent low protein C has a different risk discussion than a person with mild low activity discovered during temporary illness.
Severe inherited protein C deficiency in newborns is different from the adult form. It can cause purpura fulminans, a serious condition with widespread clotting in small blood vessels, skin bleeding, tissue injury, and risk of organ damage. This requires urgent specialist care, protein C replacement when available, and anticoagulation planning.
Protein C deficiency also has a special relationship with warfarin. Warfarin lowers protein C early in treatment. In someone with underlying protein C deficiency, this early drop can create a short prothrombotic window and rarely trigger warfarin-induced skin necrosis. This is why clinicians often overlap warfarin with heparin during initiation when treating acute thrombosis, and why a history of skin necrosis after warfarin raises suspicion for protein C pathway problems.
Protein C deficiency does not explain every clot. Common risk factors such as age, obesity, smoking, cancer, inflammation, surgery, trauma, and immobility still matter. Platelets also play a role in thrombosis, so platelet abnormalities or elevations sometimes add context. For example, a very high platelet count is evaluated differently from a natural anticoagulant deficiency, even though both relate to clot risk.
Timing, Preparation, and Test Accuracy
Accurate protein C activity testing depends heavily on timing. A poorly timed test creates confusion, unnecessary anxiety, and sometimes an incorrect inherited diagnosis.
The best time to test is usually when the person is clinically stable, recovered from an acute clot or severe illness, and not taking medications that interfere with the assay. In practice, clinicians often wait several weeks after an acute thrombosis or inflammatory illness. When warfarin has been used, testing is usually delayed until it has been stopped long enough for vitamin K-dependent proteins to recover, under medical supervision.
Preparation is usually simple. The test uses blood drawn from a vein, often into a citrate tube. The laboratory separates plasma and runs a functional assay. The blood draw itself usually takes only a few minutes.
Fasting is not always required, but some laboratories prefer fasting when possible because a very lipemic sample can interfere with functional assays. A high-fat meal before testing raises triglycerides in some people and makes the sample cloudy. Follow the specific instructions from the ordering clinician or laboratory.
Several factors reduce accuracy:
- Testing during acute thrombosis
- Testing during severe infection, inflammation, sepsis, or DIC
- Warfarin or other vitamin K antagonist therapy
- Recent vitamin K deficiency or correction
- Significant liver disease
- Heparin or direct oral anticoagulant interference, depending on assay method
- Marked lipemia, hemolysis, or high bilirubin in the sample
- Using adult ranges for infants or children
The laboratory method also matters. Chromogenic protein C activity assays are widely used because they have good specificity for many forms of deficiency. Clot-based assays detect function through clotting time and are more vulnerable to interference from lupus anticoagulant, factor V Leiden, high factor VIII, and some anticoagulants. In rare cases, one method misses a variant that another method detects, so hematology input is useful when the clinical story strongly suggests deficiency despite unclear test results.
A normal result during the right testing window makes clinically important protein C deficiency less likely. A low result during the wrong testing window should be treated as provisional, not final.
Follow-Up Tests After an Abnormal Result
A low protein C activity result usually leads to confirmation, not immediate labeling. The first question is whether the low result is real, persistent, and unexplained by acquired causes.
A practical follow-up pathway often includes:
- Review medications, especially warfarin, heparin, direct oral anticoagulants, estrogen therapy, chemotherapy, and recent vitamin K use.
- Review timing, including recent clot, surgery, pregnancy, infection, hospitalization, or inflammatory illness.
- Repeat protein C activity when the person is stable and the result will be interpretable.
- Order protein C antigen if activity remains low.
- Compare results with other thrombophilia tests and routine coagulation tests.
- Consider family testing or genetic testing when inherited deficiency is likely and results will guide care.
Protein C antigen helps separate type I from type II deficiency. Low activity with low antigen supports type I deficiency. Low activity with normal antigen supports type II deficiency. This pairing is more informative than either result alone.
Other tests often help clarify the broader clotting picture. A coagulation panel can show whether PT, INR, aPTT, fibrinogen, or D-dimer patterns suggest liver disease, DIC, anticoagulant effect, or another coagulation problem. If warfarin is involved, the INR test is central for monitoring anticoagulation intensity, but INR does not measure protein C activity directly.
Genetic testing for PROC variants is not the first step for most adults. It becomes more useful when repeated functional and antigen testing support inherited deficiency, the family history is strong, a newborn has severe disease, or family counseling will change decisions.
Family testing needs care. Testing relatives sounds straightforward, but results affect anxiety, insurance questions in some countries, reproductive planning, anticoagulation decisions, and medication choices. A hematologist or genetic counselor helps decide who benefits from testing and when to test.
The most important follow-up is clinical interpretation. A lab value alone does not decide treatment. A confirmed low protein C result means one piece of the person’s clot-risk profile is abnormal. The decision-making still includes clot type, clot trigger, number of events, bleeding risk, age, pregnancy plans, kidney and liver function, and patient preferences.
Treatment and Next Steps
Treatment focuses on the person’s clot history and risk situation, not on “fixing” a lab number. Low protein C activity is a risk marker. The main goal is to prevent dangerous clots while avoiding unnecessary bleeding from anticoagulants.
If a person has an acute deep vein thrombosis or pulmonary embolism, treatment usually involves anticoagulation. The exact medication and duration depend on the clot location, severity, trigger, bleeding risk, kidney function, pregnancy status, medication interactions, and previous clot history. A confirmed inherited protein C deficiency often strengthens the discussion about longer prevention after an unprovoked or recurrent clot, but it does not automatically mean every person needs lifelong anticoagulation.
During high-risk periods, a person with known protein C deficiency often needs a prevention plan. This is especially important around major surgery, hospitalization, prolonged immobilization, pregnancy and postpartum care, and estrogen exposure. Prevention plans are individualized and often involve a hematologist.
Estrogen-containing birth control and hormone therapy deserve special attention. Estrogen increases venous clot risk. In someone with protein C deficiency or a strong family history of clotting, clinicians often recommend non-estrogen options or a specialist review before starting estrogen-containing therapy.
Pregnancy also needs planning. Pregnancy and the postpartum period raise clot risk even without thrombophilia. A person with confirmed protein C deficiency, previous clots, or a strong family history should discuss pregnancy planning before conception when possible. The plan often covers anticoagulant safety, delivery timing, postpartum prevention, and family testing when relevant.
Severe protein C deficiency in newborns requires urgent specialist treatment. Protein C concentrate, fresh frozen plasma, anticoagulation, and intensive supportive care are used depending on availability and severity. This situation is rare but serious.
Seek urgent medical care right away for symptoms that suggest a blood clot, such as one-sided leg swelling or pain, sudden shortness of breath, chest pain that worsens with breathing, coughing blood, sudden weakness or numbness on one side, severe sudden headache, vision loss, or trouble speaking. Protein C deficiency increases concern, but symptoms drive emergency evaluation.
Questions to ask the clinician after a low result include:
- Was my test done at a reliable time?
- Could warfarin, vitamin K status, liver disease, illness, pregnancy, or another factor explain the result?
- Should the protein C activity test be repeated?
- Do I need a protein C antigen test?
- Do my relatives need testing?
- Does this result change my anticoagulation plan?
- Should I avoid estrogen-containing medications?
- What should I do before surgery, long flights, pregnancy, or hospitalization?
A low protein C activity result is important, but it is manageable when interpreted correctly. The safest path is confirmation, context, and a prevention plan matched to the person’s real clot risk.
References
- ASH VTE Guidelines: Thrombophilia Testing 2023 (Guideline)
- Thrombophilia testing: A British Society for Haematology guideline 2022 (Guideline)
- CFX – Overview: Protein C Activity, Plasma 2026 (Laboratory Test Catalog)
- Protein C and Protein S Tests 2025 (Official Medical Test)
- Protein C and S 2025 (Review)
- Protein C Deficiency 2023 (Review)
Disclaimer
This article is educational and does not replace care from a qualified healthcare professional. Protein C activity results are highly timing-sensitive and should be interpreted with medical history, medications, clot history, and other lab results. Seek urgent care for symptoms of deep vein thrombosis, pulmonary embolism, stroke, or severe unexplained bleeding.
